1. HOME
  2. 業績
  3. 業績
  4. Bibliography （英文論文） 2000年

業績

Reaserch result

業績

Bibliography （英文論文） 2000年

Bibliography （英文論文） 2000年

  1. Dowaki S, Kijima H, Kashiwagi H, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Tazawa K, Matsubayashi H, Tsuchida T, Ueyama Y, Tanaka M, Tajima T, Makuuchi H. CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol. 2000; 16: 49-53.
  2. Hatanaka H, Oshika Y, Abe Y, Yoshida Y, Hashimoto T, Handa A, Kijima H, Yamazaki H, Inoue H, Ueyama Y, Nakamura M. Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). Int J Mol Med. 2000; 5: 181-183.
  3. Ueyama Y, Abe Y, Ohnishi Y, Sawa N, Hatanaka H, Handa A, Tokuda Y, Yamazaki H, Kijima H, Tamaoki N, Nakamura M. In vivo chemosensitivity of human malignant cystsarcoma phyllodes xenografts. Oncol Reports. 2000; 7: 257-260.
  4. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Tsukui M, Tanaka Y, Matsubayashi H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Tajima T, Makuuchi H. DF3 expression in human gallbladder carcinoma: Significance for lymphatic invasion. Int J Oncol. 2000; 16: 455-459.
  5. Tokunaga T, Nakamura M, Kijima H, Yamazaki H, Ueyama Y. Letters: Response from T. Tokunaga et al. Multidrug resistance-associated protein (MRP) expression is correlated with of aberrant p53 protein in colorectal cancer. Eur J Cancer. 2000; 36: 271-272.
  6. Kijima H, Oshiba G, Kenmochi T, Kise Y, Tanaka H, Chino O, Shimada H, Ueyama Y, Tanaka M, Makuuchi H. Stromal CEA immunoreactivity is correlated with lymphatic invasion of human esophageal carcinoma. Int J Oncol. 2000; 16: 677-682.
  7. Tsuchida T, Kijima H, Hori S, Oshika Y, Tokunaga T, Kawai K, Yamazaki H, Ueyama Y, Scanlon KJ, Tamaoki N, Nakamura M. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma. Cancer Gene Ther. 2000; 7: 373-383.
  8. Kijima H, Scanlon KJ. Ribozyme as an approach for growth suppression of human pancreatic cancer. Mol Biotechnol. 2000; 14: 59-72.
  9. Kijima H, Kashiwagi H, Dowaki S, Ohtani Y, Tobita K, Matsubayashi H, Ajioka Y, Watanabe H, Tsuchida T, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Makuuchi H. Stromal sialyl Le a expression is correlated with vascular invasion of human gallbladder adenocarcinoma. Int J Oncol. 2000; 17: 55-60.
  10. Hatanaka H, Abe Y, Kamiya T, Morino F, Nagata J, Tokunaga T, Oshika Y, Suemizu H, Kijima H, Tsuchida T, Yamazaki H, Inoue H, Nakamura M, Ueyama Y. Clinical implications of interleukin (IL)-10 induces by non-small cell lung cancer. Ann Oncol. 2000; 11: 815-819.
  11. Handa A, Tokunaga T, Tsuchida T, Lee YH, Kijima H, Yamazaki H, Ueyama Y, Fukuda H, Nakamura M. Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol. 2000; 17: 291-295.
  12. Nakamura M, Abe Y, Katoh Y, Oshika Y, Hatanaka H, Tsuchida T, Yamazaki H, Kijima H, Inoue H, Ueyama Y. A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration. Anticancer Res. 2000; 20: 1921-1926.
  13. Morino F, Tokunaga T, Tsuchida T, Handa A, Nagata J, Tomii Y, Kijima H, Yamazaki H, Watanabe N, Matsuzaki S, Ueyama Y, Nakamura M. Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in a human hepatocellular carcinoma cell line. Int J Oncol. 2000; 17: 495-499.
  14. Kondo E, Furukawa T, Yoshinaga K, Kijima H, Semba S, Yatsuoka T, Yokoyama T, Fukushige S, Horii A. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability. Int J Oncol. 2000; 17: 535-541.
  15. Muramatsu T, Kijima H, Tsuchida T, Tokunaga T, Oshika Y, Konagaya M, Matsubayashi H, Tada N, Yamazaki H, Tamaoki N, Nakamura M, Ueyama Y. Acinar-islet cell tumor of the pancreas – Report of a malignant pancreatic composite tumor with exocrine and endocrine differentiation. J Clin Gastroenterol. 2000; 31: 175-178.
  16. Oshiba G, Kijima H, Tanaka H, Kenmochi T, Himeno H, Kise Y, Nishi T, Chino O, Shimada H, Abe Y, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Makuuchi H. Frequent expression of sialyl Le a in human esophageal squamous cell carcinoma. Int J Oncol. 2000; 17: 701-705.
  17. Tokunaga T, Tsuchida T, Kijima H, Okamoto K, Oshika Y, Sawa N, Ohnishi Y, Miura S, Yamazaki H, Ueyama Y, Nakamura M. Ribozyme-mediated inactivation of mutant K-ras oncogene in colon cancer. Br J Cancer. 2000; 83: 833-839.
  18. Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Oshiba G, Kise Y, Kenmochi T, Himeno H, Tajima T, Tsuchida T, Kawai K, Tanaka M, Makuuchi H. Clinicopathological studies of esophageal carcinomsarcoma: Analyses of its morphological characteristics using endoscopic, histological and immunohistochemical procedures. Endoscopy. 2000; 32: 706-711.
  19. Kondo H, Mori S, Takino H, Kijima H, Yamasaki H, Ozaki M, Tetsuya I, Urata Y, Abe T, Sera Y, Yamakawa K, Kawasaki E, Yamaguchi Y, Kondo T, Eguchi K. Attenuation of expression of g-glutamylcysteine synthetase by ribozyme transfection enhance insulin secretion by pancreatic beta cell line, MIN6. Biochem Biophys Res Commun. 2000; 278: 236-240.
  20. Oshika Y, Nakamura M, Tokunaga T, Ohnishi Y, Abe Y, Tsuchida T, Tomii Y, Kijima H, Yamazaki H, Ozeki Y, Tamaoki N, Ueyama Y. Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer. Eur J Cancer. 2000; 36 : 2390-2396.
  21. Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Oshiba G, Kise Y, Kajiwara H, Tsuchida T, Tanaka M, Tajima T, Makuuchi H. Clinicopathologycal studies of esophageal carcinoma in acalasia: Analyses of its carcinogenesis using histological and immunohistochemical procedures. Anticancer Res. 2000; 20: 3717-3722.